Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/9/2004


1.		Phase III Study of Topical Therapy of Psoralen With Phototherapy (PUVA), Nitrogen Mustard (Mechlorethamine HCL) Chemotherapy, or Total Skin Electron Beam (TSE) Alone vs One Topical Therapy Combined With Interferon Alfa-2b for Cutaneous T-Cell Lymphoma (CTCL)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				ECOG-1495 E1495


2.		Phase III Comparison of Electron Beam Radiotherapy plus ADR/CTX/VP-16/VCR vs Topical Therapy for Stage I/II/III/IV Mycosis Fungoides and Sezary Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				NCI-79-C-70 NCI-NMOB-816, NCI-T83-1451N, NCI-N81-900, N81-0900


3.		Phase III Alternating Combination Chemotherapy with CVP (CTX/VCR/PRED) and VP-16/MTX plus Phototherapy or Electron Beam Therapy in Patients with Cutaneous T-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NU-83H3 NCI-V85-0142

Last Modified: 8/1/1989


4.		Phase I/II Study of Roferon-A plus PUVA Therapy in Patients with Cutaneous T-Cell Lymphoma (Summary Last Modified 08/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				over 18								UCHSC-88036 NCI-V88-0558

Last Modified: 11/1/1995


5.		Phase II Study of Immune Stimulation by Infusion of Autologous Buffy Coat Cells Treated In Vitro with Methoxsalen and Ultraviolet Radiation in Patients with Metastatic Melanoma, Renal Cell Carcinoma, or Nonsmall Cell Lung Cancer (Summary Last Modified 11/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18				Other				YALE-HIC-7679 NCI-V94-0554

Last Modified: 12/1/1998


6.		Phase II Study of PUVA with Cyclosporine and Thalidomide as Treatment for Chronic Graft-Versus-Host Disease (Summary Last Modified 12/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				any age				Other				JHOC-9319 JHUSM-FDR001240, NCI-V96-0896

Last Modified: 1/1/1999


7.		Phase II Study of the UVAR Photopheresis System in Conjunction with Methoxsalen (Uvadex) for the Treatment of Chronic Graft Versus Host Disease (Summary Last Modified 01/99)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				not specified				Pharmaceutical / Industry				RPCI-DS-96-12 THERAKOS-RPCI-DS-96-12, NCI-G97-1239

Last Modified: 3/1/2006 First Published: 2/1/2002


8.		Phase II Randomized Study of Bexarotene and Ultraviolet A Light Therapy With Methoxsalen (PUVA) in Patients With Stage IB or IIA Cutaneous T-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				MILL-61896 LIGAND-MILL-61896, NU-IRB-837-002, NCT00030589

Last Modified: 9/1/1997


9.		Phase II/III Study of Ultraviolet Irradiation of Leukocytes During Plasmapheresis (Photopheresis) Following Administration of the Photosensitizer Methoxsalen in Patients with Cutaneous T-Cell Lymphoma (Summary Last Modified 09/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				16 and over				Other				MDA-DM-87100 NCI-V88-0342

Last Modified: 10/29/2008 First Published: 3/24/2003


10.		Phase II Study of a Reduced Toxicity Conditioning Regimen Followed By Allogeneic Bone Marrow Transplantation in Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				18 and over				NCI				ECOG-1402 NCT00057954, E1402

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute